Overview

Joseph's practice focuses on corporate finance and mergers and acquisitions. He advises public and private companies, investment dealers, venture capital and private equity funds and acts as independent counsel to boards of directors. Joseph has extensive experience advising on all types of merger and acquisition and corporate finance transactions including public and private equity and debt financings, take-over and issuer bids, share and asset acquisitions and divestitures, and regulatory and stock exchange compliance work.

Prior to his career in law, Joseph worked in corporate finance with a national investment bank and in clinical research with a multinational pharmaceutical company.

Xenon in connection with its US$747.5-million prospectus offering of common shares

Eupraxia in connection with its US$63.2-million MJDS prospectus offering of common shares

NervGen in connection with its US$10-million non-brokered private placement of units

enGene in connection with its US$150-million prospectus offering of common shares and pre-funded warrants

Eupraxia in connection with its US$80.5-million MJDS prospectus offering of common shares

Weyerhaeuser in connection with the sale of its Princeton, British Columbia lumber mill to the Gorman Group

Practice Areas

• Corporate & Commercial Law
• Securities

Bar Information

Called to the bar: 1997 (BC)

Downloads

• vCard on firm website